ProfileGDS5822 / ILMN_1223072
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 60% 2% 35% 4% 13% 3% 4% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 128.360
GSM1276600PDAC Late Ablation Control 27.32
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.735
GSM1276603PDAC Late Ablation 25.54
GSM1276604PDAC Late Ablation 39.313
GSM1303940PDAC Late Ablation_anti-CTLA4 15.73
GSM1303941PDAC Late Ablation_anti-CTLA4 244
GSM1303942PDAC Late Ablation_anti-CTLA4 3